Zydus announces USFDA Orphan Drug Designation for Usnoflast in ALS treatment

23rd January 2025 Uncategorised 0

Orphan drug designation offers development incentives and potential market exclusivity

More: Zydus announces USFDA Orphan Drug Designation for Usnoflast in ALS treatment
Source: News